Earnings To Watch: Insulet (PODD) Reports Q4 Results Tomorrow
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Wednesday morning. Here’s what to look for.
Insulet beat analysts’ revenue expectations by 3.9% last quarter, reporting revenues of $706.3 million, up 29.9% year on year. It was an exceptional quarter for the company, with revenue guidance for next quarter exceeding analysts’ expectations and a solid beat of analysts’ revenue estimates.
This quarter, analysts are expecting Insulet’s revenue to grow 28.6% year on year to $768.2 million, improving from the 17.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.46 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Insulet has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 5.3% on average.
Looking at Insulet’s peers in the healthcare equipment and supplies segment, some have already reported their Q4 results, giving us a hint as to what we can expect. ResMed delivered year-on-year revenue growth of 11%, beating analysts’ expectations by 1.6%, and DexCom reported revenues up 13.1%, topping estimates by 0.8%. ResMed’s stock price was unchanged after the resultswhile DexCom was up 7.6%.
The euphoria surrounding Trump’s November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the healthcare equipment and supplies stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.7% on average over the last month. Insulet is down 14.6% during the same time and is heading into earnings with an average analyst price target of $369.64 (compared to the current share price of $242.74).
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Breaking SpaceX's Record! Anthropic (ANT.US) IPO Raises $8.13 Billion, Priced Above Guidance Range, Landing on Nasdaq Tonight
Anthropic (ANT.US) and its seven co-founders raised a total of $81.3 billion through a large-scale IPO, becoming the first cutting-edge AI lab to secure funding for intelligent machine development via the public market.
INJ market cap at $694 million, SEC registration highlights no maximum supply
Jensen Huang's Return Hopes Dashed! Nvidia (NVDA.US) Accelerates Search for "New Leader", Arm (ARM.US) CEO Rene Haas Enters Candidate List
The headhunter firm Heidrick & Struggles, hired by Nvidia, has approached Arm Holdings CEO Rene Haas, considering him as a potential candidate for Nvidia's new leader.

Largest decline in half a year! Overseas U.S. Treasury holdings saw a sharp drop in September, with the top three "creditors"—China, Japan, and the UK—all reducing their holdings; China’s holdings hit a new low since 2008
According to the U.S. Treasury's TIC report, foreign holdings of U.S. Treasury bonds in September decreased by $75.5 billion compared to the previous month. U.S. long-term capital net inflows were $155.3 billion, shrinking by nearly 46% compared to August. Overseas investors made net purchases of $80.8 billion in U.S. Treasuries, down 26% from August. Japan’s holdings declined for the fifth consecutive month, hitting a 21-month low. Mainland China’s holdings decreased by $26.8 billion, with a reduction of over $130 billion in the past year. The UK’s holdings fell by $8.7 billion after two consecutive months of record highs. Among the top ten "creditors", only three increased their holdings in September, with France seeing the largest decrease, reducing by $31.4 billion.

